Table 3 Physical and hormonal characteristics of initial and follow-up measurements for participants who underwent follow-up measurements
| Â | Initial measurement | Follow-up measurement | ||
|---|---|---|---|---|
| Â | N | Mean | N | Mean |
Age (years) | 142 | 45.01 ± 2.63 | 142 | 46.42 ± 2.75 |
Weight (kg) | 142 | 55.60 ± 9.57 | 142 | 55.9 ± 9.82 |
Height (cm) | 141 | 159.05 ± 5.79 | 142 | 158.89 ± 5.85 |
Body mass index | 141 | 21.92 ± 3.37 | 142 | 22.12 ± 3.51 |
Systolic blood pressure (mmHg) | 138 | 122.26 ± 11.65 | 140 | 121.54 ± 12.48 |
Diastolic blood pressure (mmHg) | 137 | 78.83 ± 9.40 | 140 | 78.46 ± 9.51 |
FSH (mIU/mL) | 139 | 32.74 ± 41.58 | 136 | 42.37 ± 40.48 |
E2 (pg/mL) | 138 | 91.51 ± 108.28 | 136 | 78.08 ± 99.07 |
TSH (μIU/mL) | 136 | 1.79 ± 1.17 | 131 | 1.76 ± 0.94 |
Free T4 (μg/dL) | 136 | 1.08 ± 0.16 | 131 | 1.15 ± 0.17 |
AMH (ng/mL) | 117 | 0.35 ± 0.59 | 93 | 0.18 ± 0.40 |
TRACP-5b (mU/dL) | 121 | 244.67 ± 117.58 | 99 | 217.63 ± 117.75 |
BMD (g/cm2) | 142 | 1.15 ± 0.16 | 141 | 1.14 ± 0.15 |
BMD change (g/cm2) | 141 | 0.02 ± 0.02 |  |  |
BMD rate of change (%/year) | 141 | − 0.53 ± 2.55 |  |  |
Interval between initial and follow-up visit (years) | 141 | 1.41 ± 0.53 |  |  |
Current hormonal therapy (%) | 83 | 58.45 | Â | Â |
Surgical treatment (%) | 122 | 85.92 | Â | Â |
Residual ovary | Â | Â | Â | Â |
Bilateral (%) | 90 | 63.38 | Â | Â |
Unilateral (%) | 48 | 33.80 | Â | Â |
None (%) | 4 | 2.82 | Â | Â |
Postmenopausal (%) | 53 | 37.32 | Â | Â |
Age at menopause (years) |  | 46.77 ± 3.41 |  |  |